Conference Looks At Public Interest In South Africa’s Draft Copyright Bill 13/08/2015 by Linda Daniels for Intellectual Property Watch 4 Comments PRETORIA, SOUTH AFRICA – A conference here this week elicited a robust debate amongst intellectual property stakeholders in South Africa about the objectives of the far-reaching draft Copyright Amendment Bill.
Finding The Right Balance Between IP And Access To Science 03/08/2015 by Jos̩phine De Ruyck for Intellectual Property Watch 1 Comment STRASBOURG РAs UN Special Rapporteur Farida Shaheed prepares to finalise a second consecutive report on the connection between the right to science and culture and patent policy, two well-known academics took the floor at the University of Strasbourg Centre for International Intellectual Property Studies (CEIPI) recently to share their views and hopes for this long-awaited paper.
WIPO Patent Committee Agrees On Future Work, After Uncertainty 01/08/2015 by Catherine Saez, Intellectual Property Watch Leave a Comment The World Intellectual Property Organization patent law committee today agreed on work programme going forward that includes a balance of North-South issues such as patent quality, patents and health, client-attorney privilege, technology transfer, and exceptions to patents. Agreement on the work program was difficult despite a comparatively fast-moving week of progress on these same areas of work.
IP-Watch Seeks Part-Time Fundraising/Outreach Expert 31/07/2015 by Intellectual Property Watch Leave a Comment Intellectual Property Watch is seeking a dynamic person to help expand our fundraising and outreach activities. [Position closed]
WHO Heralds Breakthrough On Ebola Vaccine: “Turning Point In History Of Health R&D” 31/07/2015 by Catherine Saez, Intellectual Property Watch Leave a Comment The World Health Organization announced today that a vaccine preventing Ebola has proved efficacious in Ebola-stricken Guinea, hailing it as a “turning point in the history of health R&D.”
Medicines Patent Pool At 5 Years: Promises Kept, Changes Ahead – An Interview With Greg Perry 30/07/2015 by Catherine Saez, Intellectual Property Watch Leave a Comment The Medicines Patent Pool in Geneva is celebrating five years of existence this month. MPP Executive Director Greg Perry sat down with Intellectual Property Watch Catherine Saez to describe progress made since its inception, the success of its licensing agreement model, and plans for the future, including a possible extension to other diseases such as tuberculosis and hepatitis C.
Special Feature: Differences Over GIs Threaten 2016/2017 WIPO Budget Approval 30/07/2015 by William New, Intellectual Property Watch 2 Comments The UN World Intellectual Property Organization is a member-driven agency set up to protect IP rights worldwide. In recent years, an area of dissension and debate has been how to make the organisation – and IPRs – friendlier to developing countries. This year, however, it has become a hotspot for the global debate between developed countries over protection of geographical indications, products of distinctive character deriving from specific locations.
WIPO Model Law Needs Revision, Developing Countries Say; Developed Countries Reluctant 30/07/2015 by Catherine Saez, Intellectual Property Watch 2 Comments The World Intellectual Property Organization provides legislative assistance to developing countries and least-developed countries upon request by individual member states. This week at the WIPO patent law committee, the Latin American and Caribbean Group tabled a proposal to revise the 1979 WIPO model law for developing countries on inventions, arguing it is obsolete.
WIPO Patent Committee Searching For Common Ground For Future Discussions 29/07/2015 by Catherine Saez, Intellectual Property Watch Leave a Comment After a slow start this week due to late approval of the agenda, the World Intellectual Property Organization patent law committee is now sailing through the proposed schedule. However, previous positions remain unchanged and the core issue of the session is to find common ground on the future work of the committee.
Panel: Biotech Industry Executives Shine Light On Their IP Management Strategies 29/07/2015 by Rishi Dhir for Intellectual Property Watch Leave a Comment “IP is a very crucial part of our business and I can’t imagine being in biotech without a very strong emphasis on intellectual property,” a biotech industry executive said during a panel organised at the World Intellectual Property Organization yesterday.